| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:98.)
© 2006 American Heart Association, Inc.
Original Contributions |
From the Division of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK.
Correspondence to Professor J.M. Wardlaw, Division of Clinical Neurosciences, Bramwell-Dott Building, Western General Hospital, Crewe Rd, Edinburgh, EH4 2XU, UK. E-mail jmw{at}skull.dcn.ed.ac.uk
Background and Purpose An acute mismatch on diffusion-weighted MRI (DWI) and perfusion-weighted MRI (PWI) may represent the "tissue-at-risk." It is unclear which "semiquantitative" perfusion parameter most closely identifies final infarct volume.
Methods Acute stroke patients underwent DWI and PWI (dynamic-susceptibility contrast imaging) on admission (baseline), and T2-weighted imaging (T2WI) at 1 or 3 months after stroke. "Semiquantitative" mean transit time (MTTsq=first moment of concentration/time curve), cerebral blood volume (CBVsq=area under concentration/time curve), and cerebral blood flow (CBFsq=CBVsq/MTTsq) were calculated. DWI and PWI lesions were measured at baseline and final infarct volume on T2WI acquired
1 month after stroke. Baseline DWI, CBFsq, and MTTsq lesion volumes were compared with final T2WI lesion volume.
Results Among 46 patients, baseline DWI and CBFsq lesions were not significantly different from final T2WI lesion volume, but baseline MTTsq lesions were significantly larger. The correlation with final T2WI lesion volume was strongest for DWI (Spearman rank correlation coefficient
=0.68), intermediate for CBFsq (
=0.55), and weakest for MTTsq (
=0.49) baseline lesion volumes. Neither DWI/CBFsq nor DWI/MTTsq mismatch predicted lesion growth; lesion growth was equally common in those with and without mismatch.
Conclusions Of the 2 PWI parameters, CBFsq lesions most closely identifies, and MTTsq overestimates, final T2WI lesion volume. "DWI/PWI mismatch" does not identify lesion growth. Patients without "DWI/PWI mismatch" are equally likely to have lesion growth as those with mismatch and should not be excluded from acute stroke treatment.
Key Words: cerebrovascular disorders imaging, diffusion-weighted imaging, perfusion-weighted magnetic resonance imaging stroke
This article has been cited by other articles:
![]() |
V.W. Mark, E. Taub, C. Perkins, L.V. Gauthier, G. Uswatte, and J. Ogorek Poststroke Cerebral Peduncular Atrophy Correlates with a Measure of Corticospinal Tract Injury in the Cerebral Hemisphere AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 354 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kane, T. Carpenter, F. Chappell, C. Rivers, P. Armitage, P. Sandercock, and J. Wardlaw Comparison of 10 Different Magnetic Resonance Perfusion Imaging Processing Methods in Acute Ischemic Stroke: Effect on Lesion Size, Proportion of Patients With Diffusion/Perfusion Mismatch, Clinical Scores, and Radiologic Outcomes Stroke, December 1, 2007; 38(12): 3158 - 3164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ciccone, L. Valvassori, R. Gasparotti, F. Scomazzoni, E. Ballabio, and R. Sterzi Debunking 7 Myths That Hamper the Realization of Randomized Controlled Trials on Intra-Arterial Thrombolysis for Acute Ischemic Stroke Stroke, July 1, 2007; 38(7): 2191 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jacobs, T. S. Ibrahim, and R. Ouwerkerk AAPM/RSNA Physics Tutorials AAPM/RSNA Physics Tutorials for Residents: MR Imaging: Brief Overview and Emerging Applications RadioGraphics, July 1, 2007; 27(4): 1213 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Lansberg, V. N. Thijs, S. Hamilton, G. Schlaug, R. Bammer, S. Kemp, G. W. Albers, and on behalf of the DEFUSE Investigators Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE Stroke, June 1, 2007; 38(6): 1826 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Woitzik, P. G. Pena-Tapia, U. C. Schneider, P. Vajkoczy, and C. Thome Cortical Perfusion Measurement by Indocyanine-Green Videoangiography in Patients Undergoing Hemicraniectomy for Malignant Stroke Stroke, June 1, 2006; 37(6): 1549 - 1551. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |